Phentermine

Phentermine
Clinical data
Trade namesAdipex-P, Ionamin, Suprenza, others
Other namesα,α-Dimethylphenethylamine; α,α-Dimethylphenylethylamine; α-Methylamphetamine
AHFS/Drugs.comMonograph
MedlinePlusa682187
Pregnancy
category
  • AU: B3
Dependence
liability
Physical: Not typical
Psychological: Moderate
Addiction
liability
Low
Routes of
administration
By mouth
Drug classPsychostimulant; Appetite suppressant; Norepinephrine–dopamine releasing agent
ATC code
Legal status
Legal status
Pharmacokinetic data
BioavailabilityHigh (almost 100%)
Protein binding17.5%
MetabolismMinimal (6%)
Elimination half-life20–25 hours, urinary pH-dependent
ExcretionUrine (62–85% unchanged)
Identifiers
  • 2-methyl-1-phenylpropan-2-amine
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.004.112
Chemical and physical data
FormulaC10H15N
Molar mass149.237 g·mol−1
3D model (JSmol)
  • NC(Cc1ccccc1)(C)C
  • InChI=1S/C10H15N/c1-10(2,11)8-9-6-4-3-5-7-9/h3-7H,8,11H2,1-2H3 Y
  • Key:DHHVAGZRUROJKS-UHFFFAOYSA-N Y
  (verify)

Phentermine, sold under the brand name Adipex-P among others, is a medication used together with diet and exercise to treat obesity. It is available by itself or as the combination phentermine/topiramate. Phentermine is taken by mouth.

Common side effects include a fast heart beat, high blood pressure, trouble sleeping, dizziness, and restlessness. Serious side effects may include abuse, but do not include pulmonary hypertension or valvular heart disease, as the latter complications were caused by the fenfluramine component of the "fen-phen" combination. Phentermine is a norepinephrine and dopamine releasing agent (NDRA) and produces stimulant, rewarding, and appetite suppressant effects. Chemically, it is a substituted amphetamine.

Phentermine was approved for medical use in the United States in 1959. It is available as a generic medication. In 2022, it was the 149th most commonly prescribed medication in the United States, with more than 3 million prescriptions. Phentermine was withdrawn from the market in the United Kingdom in 2000, while the combination medication fen-phen, of which it was a part, was withdrawn from the market in 1997 due to side effects of fenfluramine.